In this episode of Motley Cool Hidden Gems Investing, hosts Travis William, Lou Whiteman, and Rachel Warren discuss three major financial stories: a potential acquisition of PayPal, Johnson & Johnson's latest earnings, and Uber's lobbying efforts concerning autonomous vehicles in Washington D.C.
**PayPal Acquisition Rumors: Stripe and Advent International's Bid**
The program opens with breaking news regarding a joint confidential proposal from payments giant Stripe and private equity firm Advent International to acquire PayPal. The offer stands at $60.50 per share, valuing PayPal at over $53 billion, representing a 28% premium over its previous day's closing price. This deal, backed by $50 billion in committed bank financing, proposes a 50-50 joint partnership where Stripe and Advent would equally run PayPal, keeping the company intact rather than breaking it up.
Rachel Warren points out the significant drop in PayPal's valuation since its pandemic peak of $360 billion in 2021. The timing is notable, as PayPal is undergoing an internal transition with a new CEO implementing a turnaround plan targeting over $1 billion in cost savings. For Stripe, a private company with an estimated $160 billion valuation, this acquisition could massively scale its footprint, granting access to hundreds of millions of consumer accounts and integrating PayPal's consumer brand with Stripe's backend infrastructure. It would also absorb PayPal's stablecoin into its ecosystem.
Lou Whiteman expresses skepticism, noting that the offer was reportedly made a month ago and the leak likely came from the acquirers to pressure PayPal into a response. While acknowledging PayPal's inherent value—its strong brand and $6 billion in free cash flow—Lou believes the private equity component (Advent) makes sense for utilizing this cash flow to pay down debt, a standard PE strategy. However, he highlights the inherent tension in a 50-50 partnership between a growth-oriented fintech like Stripe and a private equity firm with different motivations. Lou predicts PayPal will reject the offer, suggesting institutional shareholders, who comprise 75% of ownership, would likely demand a price starting at $80 per share.
Travis William raises concerns about Stripe, a private company, financing such a large acquisition, potentially with significant debt. He questions if this is a "last gasp effort" for growth, given the uncertainty about the profitability of payment infrastructure companies. The hosts also touch upon the "price discovery" issue for private companies like Stripe, whose private valuation might not hold up in public markets, making the deal complex and potentially a "convoluted mess."
**Johnson & Johnson's Earnings Report: Macro Headwinds vs. Long-Term Strength**
Johnson & Johnson (J&J) reported solid earnings, with over $25 billion in revenue (up 7%) and adjusted EPS of $2.90 (up 5%), both beating Wall Street expectations. Management also raised its full-year sales guidance to over $101 billion, marking a potential first for the company to cross the $100 billion milestone in its nearly 140-year history.
Despite the positive results, J&J's stock saw an initial dip. Rachel attributes this to a minor revenue miss in their medtech division, particularly with a slight drop in sales for their abiomed heart pumps, and "hyperfixation on short-term patent anxieties" related to their blockbuster drug Solara facing competition from biosimilars. As a long-term shareholder, Rachel views the market reaction as short-term noise, emphasizing J&J's six-decade history of increasing dividends, diversified revenue streams, and a pipeline of new blockbuster drugs with no major patent risks until the early 2030s beyond Solara.
Lou Whiteman echoes this sentiment, noting that the medtech division's struggles are likely a macro issue, not specific to J&J. He points to similar trends with other companies like Intuitive Surgical and HCA, suggesting a cyclicality in healthcare where economic woes or coverage issues can lead to a decrease in elective surgeries.
**Uber and Autonomous Vehicles: A "Nervous Incumbent" on the Defensive**
The discussion shifts to Uber's unexpected role as a "nervous incumbent" in the autonomous vehicle (AV) space, particularly in Washington D.C. Lou Whiteman highlights that Uber, once the ultimate disruptor, is now lobbying against Waymo operating independently. Uber is advocating for regulations that would require robotaxis to operate on ride-hailing networks that also employ human drivers, effectively forcing AV companies to integrate with existing platforms like Uber's.
Lou critically contrasts Uber's current stance with its disruptive origins, where it tore down regulations. He now sees them as "defenders of the horse carriage in the age of the automobile," using regulatory capture to slow down the transition to full autonomy because they lack a proprietary driverless solution. Uber's current "product" is its inventory of customers, and it wants to ensure this platform remains indispensable.
Rachel Warren adds that Uber's old playbook of aggressive lobbying, which helped it win the ride-sharing war, is now being used to counter a different threat. She points to past attempts by Uber to pass rules that would mandate a high percentage of human drivers for any driverless company. Travis notes that Uber has invested billions in various AV and EV companies like Lucid and Nuro, hoping to buy their vehicles for its network. However, these partnerships are not yet scaling effectively, while Waymo is already dominating, clearing over 500,000 commercial trips weekly. Lou further suggests that if Lucid had a viable autonomous solution, Uber would likely have acquired them already, indicating their AV technology isn't as close as some might claim. The hosts conclude that Uber, once an aggressive innovator, now finds itself in a defensive position, making investors wary.